Analyst Price Targets — SHC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 9, 2026 10:15 am | Jason Bednar | Piper Sandler | $24.00 | $18.81 | TheFly | Sotera Health upgraded to Overweight from Neutral at Piper Sandler |
| January 8, 2026 9:05 pm | Ryan Halstead | RBC Capital | $24.00 | $18.81 | StreetInsider | RBC Capital Starts Sotera Health (SHC) at Outperform |
| November 5, 2025 2:22 pm | — | Piper Sandler | $17.00 | $16.15 | TheFly | Sotera Health price target raised to $17 from $15 at Piper Sandler |
| November 5, 2025 11:20 am | — | Barclays | $20.00 | $16.43 | TheFly | Sotera Health price target raised to $20 from $19 at Barclays |
| October 2, 2025 10:44 am | — | Barclays | $19.00 | $16.19 | TheFly | Sotera Health price target raised to $19 from $17 at Barclays |
| May 5, 2025 8:22 am | Matthew Sykes | Goldman Sachs | $17.00 | $12.92 | TheFly | Sotera Health upgraded to Buy from Neutral at Goldman Sachs |
| December 5, 2024 9:03 pm | David Windley | Jefferies | $15.00 | $12.98 | StreetInsider | Sotera Health (SHC) PT Lowered to $15 at Jefferies |
| November 6, 2024 11:19 am | David Windley | Jefferies | $18.00 | $15.27 | StreetInsider | Sotera Health (SHC) PT Raised to $18 at Jefferies |
| August 6, 2024 5:43 am | Luke Sergott | Barclays | $17.00 | $14.22 | TheFly | Sotera Health price target raised to $17 from $14 at Barclays |
| June 6, 2024 5:52 am | David Windley | Jefferies | $14.50 | $11.98 | StreetInsider | Sotera Health (SHC) PT Raised to $14.50 at Jefferies |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for SHC

CLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25 million shares of its common stock, par value $0.01 per share. All 25 million shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders.

Sotera Health delivers sterilization and laboratory solutions to healthcare, pharmaceutical, and food industry clients worldwide.

Sotera Health Company (SHC) Q4 2025 Earnings Call Transcript

While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Sotera Health Company (SHC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SHC.
U.S. House Trading
No House trades found for SHC.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
